Modulation of peanut-induced allergic immune responses by oral lactic acid bacteria-based vaccines in mice

Applied Microbiology and Biotechnology

Volumn 98, Issue 14, 2014, Pages 6353-6364

  Ren, Chengcheng ^a   Zhang, Qiuxiang ^a   Wang, Gang ^a   Ai, Chunqing ^a   Hu, Mengsha ^a   Liu, Xiaoming ^a   Tian, Fengwei ^a   Zhao, Jianxin ^a   Chen, Yongquan ^a,b   Wang, Miao ^a   Zhang, Hao ^a   Chen, Wei ^a,b  

^a JIANGNAN UNIVERSITY   (China)

^b Synergetic Innovation Center of Food Safety and Nutrition   (China)

Author keywords

Immunomodulation; Lactococcus lactis; Oral tolerance; Peanut allergy

Indexed keywords

ALLERGENS; ALLERGIES; BACTERIA; IMMUNE SYSTEM; MAMMALS; OILSEEDS; STRAIN; T-CELLS; VACCINES;

GENETICALLY MODIFIED; IMMUNO MODULATIONS; LACTIC ACID BACTERIA; LACTOCOCCUS LACTIS; MANAGEMENT STRATEGIES; ORAL TOLERANCES; PEANUT ALLERGIES; REGULATORY T CELLS;

LACTIC ACID;

ANTIBODY; BACTERIAL PROTEIN; BACTERIAL VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LACTOCOCCUS LACTIS VACCINE; PROTEIN ARA H 2; UNCLASSIFIED DRUG; ALLERGEN; RECOMBINANT VACCINE; SECRETORY IMMUNOGLOBULIN;

ALLERGY; BACTERIUM; BIOTECHNOLOGY; DISEASE TREATMENT; GENE EXPRESSION; GENETICALLY MODIFIED ORGANISM; GROUNDNUT; IMMUNE RESPONSE; MUCUS; PROBIOTICS; RECOMBINATION; RODENT; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; FECES ANALYSIS; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEANUT ALLERGY; PEANUT INDUCED ALLERGIC IMMUNE RESPONSE; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; WESTERN BLOTTING; ANIMAL; DNA SEQUENCE; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; MOUTH; ORAL DRUG ADMINISTRATION; PEANUT; TH1 CELL; TH2 CELL;

ARA; ARACHIS HYPOGAEA; LACTOCOCCUS LACTIS; MUS;

ADMINISTRATION, ORAL; ALLERGENS; ANIMALS; ARACHIS HYPOGAEA; BACTERIAL VACCINES; HYPERSENSITIVITY; IMMUNOGLOBULIN A, SECRETORY; LACTOCOCCUS LACTIS; MICE; MOLECULAR SEQUENCE DATA; MOUTH; SEQUENCE ANALYSIS, DNA; TH1 CELLS; TH2 CELLS; VACCINES, SYNTHETIC;

EID: 84903587761     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-014-5678-7     Document Type: Article

References (54)

1. Adel-Patient K, Ah-Leung S, Creminon C, Nouaille S, Chatel JM, Langella P, Wal JM (2005) Oral administration of recombinant Lactococcus lactis expressing bovine β-lactoglobulin partially prevents mice from sensitization. Clin Exp Allergy 35(4):539-546 (Pubitemid 40577249)
2. Allez M, Mayer L (2004) Regulatory T cells. Peace keepers in the gut. Inflamm Bowel Dis 10(5):666-676 (Pubitemid 39276480)
3. Al-Muhsen S, Clarke AE, Kagan RS (2003) Peanut allergy: an overview. Can Med Assoc J 168(10):1279-1285 (Pubitemid 36609907)
4. Asadullah K, Sterry W, Volk HD (2003) Interleukin-10 therapy - review of a new approach. Pharmacol Rev 55(2):241-269 (Pubitemid 36666048)
5. Bahey-El-Din M, Casey PG, Griffin BT, Gahan CGM (2008) Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8+ T cells against Listeria monocytogenes in the murine infection model. Vaccine 26(41):5304-5314
6. Böttcher MF, Häggström P, Björkstén B, Jenmalm MC (2002) Total and allergen-specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age. Clin Exp Allergy 32(9):1293-1298 (Pubitemid 35024954)
7. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon JP, van Deventer SJH, Neirynck S, Peppelenbosch MP, Steidler L (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 4(6):754-759 (Pubitemid 43841860)
8. Burks AW (2008) Peanut allergy. Lancet 371(9623):1538-1546
9. Burks AW, Williams LW, Connaughton C, Cockrell G, O'Brien TJ, Helm RM (1992) Identification and characterization of a second major peanut allergen, Ara h II, with use of the sera of patients with atopic dermatitis and positive peanut challenge. J Allergy Clin Immunol 90(6, Part 1):962-969 (Pubitemid 23004593)
10. Capobianco F, Butteroni C, Barletta B, Corinti S, Afferni C, Tinghino R, Boirivant M, Di Felice G (2008) Oral sensitization with shrimp tropomyosin induces in mice allergen-specific IgE, T cell response and systemic anaphylactic reactions. Int Immunol 20(8):1077-1086
11. Cheun HI, Kawamoto K, Hiramatsu M, Tamaoki H, Shirahata T, Igimi S, Makino SI (2004) Protective immunity of SpaA-antigen producing Lactococcus lactis against Erysipelothrix rhusiopathiae infection. J Appl Microbiol 96(6):1347-1353 (Pubitemid 38703616)
12. Coffman RLVK, Scott P, Chatelain R (1991) Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev 123:189-207
13. Cortes-Perez NG, Lefèvre F, Corthier G, Adel-Patient K, Langella P, Bermúdez-Humarán LG(2007) Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 25(36):6581-6588 (Pubitemid 47224988)
14. Daniel C, Repa A, Wild C, Pollak A, Pot B, Breiteneder H, Wiedermann U, Mercenier A (2006) Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 61(7):812-819 (Pubitemid 43893983)
15. Daniel C, Sebbane F, Poiret S, Goudercourt D, Dewulf J, Mullet C, Simonet M, Pot B (2009) Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV. Vaccine 27(8):1141-1144
16. Foligne B, Dessein R, Marceau M, Poiret S, Chamaillard M, Pot B, Simonet M, Daniel C (2007) Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology 133(3):862-874 (Pubitemid 47374132)
17. Frossard CP, Steidler L, Eigenmann PA (2007) Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J Allergy Clin Immunol 119(4):952-959 (Pubitemid 46527811)
18. Gasson MJ (1983) Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol 154(1):1-9
19. Hazebrouck S, Oozeer R, Adel-Patient K, Langella P, Rabot S, Wal J-M, Corthier G (2006) Constitutive delivery of bovine β-lactoglobulin to the digestive tracts of gnotobiotic mice by engineered Lactobacillus casei. J Appl Microbiol 72(12):7460-7467 (Pubitemid 44927645)
20. Hazebrouck S, Przybylski-Nicaise L, Ah-Leung S, Adel-Patient K, Corthier G, Langella P, Wal JM (2009) Influence of the route of administration on immunomodulatory properties of bovine β-lactoglobulin-producing Lactobacillus casei. Vaccine 27(42):5800-5805
21. Holo H, Nes IF (1989) High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. J Appl Microbiol 55(12):3119-3123 (Pubitemid 20002122)
22. Huibregtse IL, Snoeck V, de Creus A, Braat H, de Jong EC, van Deventer SJH, Rottiers P (2007) Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin. Gastroenterology 133(2):517-528 (Pubitemid 47187339)
23. Husain Z, Schwartz RA (2012) Peanut allergy: an increasingly common life-threatening disorder. J Am Acad Dermatol 66(1):136-143
24. Jing H, Yong L, Haiyan L, Yanjun M, Yun X, Yu Z, Taiming L, Rongyue C, Liang J, Jie W, Li Z, Jingjing L (2011) Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice. Vaccine 29(24):4102-4109
25. Josefowicz SZ, Lu LF, Rudensky AY (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30:531-564
26. Koppelman SJ, Knol EF, Vlooswijk RAA, Wensing M, Knulst AC, Hefle SL, Gruppen H, Piersma S (2003) Peanut allergen Ara h 3: isolation from peanuts and biochemical characterization. Allergy 58(11):1144-1151 (Pubitemid 37372300)
27. Koppelman SJ, Wensing M, Ertmann M, Knulst AC, Knol EF (2004) Relevance of Ara h1, Ara h2 and Ara h3 in peanut-allergic patients, as determined by immunoglobulin E Western blotting, basophil- histamine release and intracutaneous testing: Ara h2 is the most important peanut allergen. Clin Exp Allergy 34(4):583-590 (Pubitemid 38534890)
28. Kui Wu YB, Kun S, Changzheng W (2007) IL-10-producing type 1 regulatory T cells and allergy. Cell Mol Immunol 4(4):269-275
29. Kuipers OP, Ruyter PG de, Kleerebezem M, Vos WM de (1998) Quorum sensing-controlled gene expression in lactic acid bacteria. J Biotechnol 64(1):15-21 (Pubitemid 29027781)
30. Le Loir Y, Azevedo V, Oliveira S, Freitas D, Miyoshi A, Bermúdez-Humarán L, Nouaille S, Ribeiro L, Leclercq S, Gabriel J, Guimaraes V, Oliveira M, Charlier C, Gautier M, Langella P (2005) Protein secretion in Lactococcus lactis : an efficient way to increase the overall heterologous protein production.Microb Cell Fact 4(1):1-13
31. Li X-M, Srivastava K, Grishin A, Huang C-K, Schofield B, Burks W, Sampson HA (2003a) Persistent protective effect of heat-killed Escherichia coli producing "engineered", recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 112(1):159-167 (Pubitemid 36819821)
32. Li X-M, Srivastava K, Huleatt JW, Bottomly K, Burks AW, Sampson HA (2003b) Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanutinduced anaphylaxis in a murine model. J Immunol 170(6):3289-3295 (Pubitemid 36302207)
33. Mannam P, Jones KF, Geller BL (2004)Mucosal vaccinemade from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun 72(6):3444-3450 (Pubitemid 38697770)
34. Marelli B, Perez AR, Banchio C, de Mendoza D, Magni C (2011) Oral immunization with live Lactococcus lactis expressing rotavirus VP8* subunit induces specific immune response in mice. J Virol Methods 175(1):28-37
35. Marinaro M, Boyaka PN, Finkelman FD, Kiyono H, Jackson RJ, Jirillo E, McGhee JR (1997) Oral but Not Parenteral Interleukin (IL)-12 Redirects T Helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med 185(3):415-428
36. Meijerink M, Wells JM, Taverne N, de Zeeuw Brouwer M-L, Hilhorst B, Venema K, van Bilsen J (2012) Immunomodulatory effects of potential probiotics in a mouse peanut sensitization model. FEMS Immunol Med Microbiol 65(3):488-496
37. Mierau I, Kleerebezem M (2005) Ten years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol 68(6):705-717 (Pubitemid 41545614)
38. Mondoulet L, Dioszeghy V, Larcher T, Ligouis M, Dhelft V, Puteaux E, Cherel Y, Letourneur F, Dupont C, Benhamou P-H (2012) Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice. PLoS ONE 7(2):e31967
39. Mosmann TR, Coffman RL (1989) TH1 and TH2 Cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173 (Pubitemid 19138011)
40. Neutra MR, Kozlowski PA (2006) Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6(2):148-158 (Pubitemid 43361590)
41. Perez CA, Eichwald C, Burrone O, de Mendoza D (2005) Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice. J Appl Microbiol 99(5):1158-1164 (Pubitemid 41531306)
42. Piard JC, Hautefort I, Fischetti VA, Ehrlich SD, Fons M, Gruss A (1997) Cell wall anchoring of the Streptococcus pyogenes M6 protein in various lactic acid bacteria. J Bacteriol 179(9):3068-3072 (Pubitemid 27194463)
43. Ramasamy R, Yasawardena S, Zomer A, Venema G, Kok J, Leenhouts K (2006) Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine 24(18):3900-3908
44. Schwarzer M, Repa A, Daniel C, Schabussova I, Hrncir T, Pot B, Stepankova R, Hudcovic T, Pollak A, Tlaskalova-Hogenova H, Wiedermann U, Kozakova H (2011) Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization. Allergy 66(3):368-375
45. Sheikh SB, Burks AW (2013) Recent advances in the diagnosis and therapy of peanut allergy. Expert Rev Clin Immunol 9(6):551-560
46. Sicherer SH, Muñoz-Furlong A, Sampson HA (2003) Prevalence of peanut and tree nut allergy in the United States determined bymeans of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol 112(6):1203-1207 (Pubitemid 37550017)
47. Skolnick HS, Conover-Walker MK, Koerner CB, Sampson HA, Burks W, Wood RA (2001) The natural history of peanut allergy. J Allergy Clin Immunol 107(2):367-374 (Pubitemid 32173917)
48. Srivastava KD, Li X-M, King N, Stanley S, Bannon GA, Burks W, Sampson HA (2002) Immunotherapy with modified peanut allergens in a murine model of peanut allergy. J Allergy Clin Immunol 109(1, Supplement 1):S287
49. Srivastava KD, Qu C, Zhang T, Goldfarb J, Sampson HA, Li X-M(2009) Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-γ-producing CD8+ T cells. J Allergy Clin Immunol 123(2):443-451
50. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, Fiers W, Remaut E (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289(5483):1352-1355 (Pubitemid 30656052)
51. Strait RT, Morris SC, Finkelman FD (2006) IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking. J Clin Invest 116(3):833-841 (Pubitemid 43326893)
52. Taylor SL, Hefle SL, Bindslev-Jensen C, Bock SA, Burks AW Jr, Christie L, Hill DJ, Host A, Hourihane JOB, Lack G, Metcalfe DD, Moneret-Vautrin DA, Vadas PA, Rance F, Skrypec DJ, Trautman TA, Yman IM, Zeiger RS (2002) Factors affecting the determination of threshold doses for allergenic foods: how much is too much? J Allergy Clin Immunol 109(1):24-30 (Pubitemid 34112125)
53. Weiner HL (2001) Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect 3(11):947-954
54. Wells JM, Mercenier A (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6(5):349-362 (Pubitemid 351552656)